Hartford HealthCare Cancer Institute at the Hospital of Central Ct — Hartford, Connecticut

Hartford HealthCare Cancer Institute at the Hospital of Central Ct is a clinical research site located in Hartford, Connecticut, United States 06053.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Hartford HealthCare Cancer Institute at the Hospital of Central Ct has participated in 1 clinical trials.

Therapeutic areas: Recurrent Platinum Resistant Ovarian Cancer.

Sponsors: Vascular Biogenics Ltd. operating as VBL Therapeutics.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hartford HealthCare Cancer Institute at the Hospital of Central Ct?

Hartford HealthCare Cancer Institute at the Hospital of Central Ct has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hartford HealthCare Cancer Institute at the Hospital of Central Ct conducted?

Hartford HealthCare Cancer Institute at the Hospital of Central Ct has 1 clinical trials on record. Their work covers Recurrent Platinum Resistant Ovarian Cancer.

Is Hartford HealthCare Cancer Institute at the Hospital of Central Ct accredited by Crixeo Health?

Hartford HealthCare Cancer Institute at the Hospital of Central Ct has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hartford HealthCare Cancer Institute at the Hospital of Central Ct?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.